Welcome to healthandbeautydieting
.com/products
Diet Products Sales Commission Article
. For a permanent link to this article, or to bookmark it for further reading, click here.
Dieting Non-sense
from: Harvey DobsonDieting Non-sense
I can really only speak for myself and think the way I think because, Im past the life expectancy chart and to my knowledge am as healthy as a 25 year old. Well, lets say 'most' 25 year olds. I have no known health issues to dispute that last statement.I dont think some balding,graying or wrinkles are health or diet issues, but probably related.
I think there are enough doctors going around in circles prescribing what the drug companies tell them to prescribe. Most doctors will tell you the truth, but turn around and prescribe some drug
recommendation. If your condition has deteriorated to the point that you put yourself in complete doctor's control - good luck
If you decide to re-gain your control, go back to what the doctor or this article will attempt to get thru to you - AGAIN!
Since theres not enough time or space here to re-build a complete case of
evidence that is as clear as being able to see the forest BECAUSE of the trees, the case and the verdict are in YOUR power.
Surely,You truly desire good health before it deteriorates to the pill level, or doctor's control, SO, etch these 3 words into your brain - The forest IS trees, and Good health IS
"FITNESS". Ok, 4 words.
www.HealthandBeautyFitness.com
Diet Products Sales Commission News
Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all ... - MarketWatch (press release)
Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all ... MarketWatch (press release) The product is also available at GNC.com and anatabloc.com. Anatabloc® was first offered to GNC customers on February 1, 2012, when the retailer began selling the product through GNC.com and on April 1 in select stores. After sales of Anatabloc® showed ... |
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... - MarketWatch (press release)
New Phase 3 data for Tradjenta® (linagliptin) tablets in black or African ... MarketWatch (press release) TRADJENTA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. TRADJENTA is a DPP-4 inhibitor that does not require dose adjustments regardless of declining renal function or hepatic ... |
CFTC Gensler talks Dodd-Frank at Senate committee meeting - Futures Magazine
 Futures Magazine | CFTC Gensler talks Dodd-Frank at Senate committee meeting Futures Magazine I am authorized by the Commission to confirm that the CFTC's Division of Enforcement has opened an investigation related to credit derivative products traded by JPMorgan Chase's Chief Investment Office. Although I am unable to provide any specific ... |
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... - MarketWatch (press release)
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... MarketWatch (press release) SAN DIEGO, CA, May 22, 2012 (MARKETWIRE via COMTEX) -- Given Imaging (NASDAQ:GIVN) , a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that new studies confirm the value of its PillCam(R) SB as a tool to help ... |
Santarus Reports First Quarter 2012 Financial Results - MarketWatch (press release)
Santarus Reports First Quarter 2012 Financial Results MarketWatch (press release) The cost of product sales was $3.5 million, or approximately 8% of net product sales, for the first quarter of 2012, compared with $1.5 million, or approximately 13% of net product sales, for the first quarter of 2011. The decrease in the cost of ... |
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... - Healthcare Global (press release)
New Studies Confirm Value of Given Imaging's PillCam(R) SB in Managing ... Healthcare Global (press release) SAN DIEGO, CA--(Marketwire - May 22, 2012) - Given Imaging ( NASDAQ : GIVN ), a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that new studies confirm the value of its PillCam ® SB as a tool to help monitor, ... |
Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012 - MarketWatch (press release)
Given Imaging Announces Strong Presence at Upcoming Digestive Disease Week(R) 2012 MarketWatch (press release) YOQNEAM, ISRAEL, May 18, 2012 (MARKETWIRE via COMTEX) -- Given Imaging (NASDAQ:GIVN) , a world leader in specialty GI products and pioneer of capsule endoscopy, today announced that a wide range of new studies will be presented at Digestive Disease ... |